Eli Lilly says its Alzheimer's drug appears to slow symptoms
Shares of the pharmaceutical company jumped almost 5% after announcing promising results for donanemab.
Eli Lilly
Eli Lilly seeks FDA approval for weight loss drug
Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising results. Nikki Battiste has more.
Eli Lilly cuts insulin prices
At a time when insulin makers are coming under increased pressure from patients and the government, Eli Lilly says it is cutting the prices and capping costs for its insulin products. Lilia Luciano reports.
Tennessee's attempt to execute Christa Pike using lethal injection fails
Co-pilot stabs pilot, tries to crash passenger jet en route to Israel, Netanyahu says
Hegseth says he's cutting generals and admirals by 20%, ousting "woke"
Details emerge in case of former Cornell student alleging rape by frat members
Live
Iran says it's considering ceasefire counterproposal
Trump unveils South Korean investment in Alaska gas pipeline
Netanyahu says it's too early to determine motive in cockpit stabbing
Trump deflects on audio of Paxton calling GOP convention a drag on polls
